Advertisement
Screener

PHARMAGEN, INC. Form D

PHARMAGEN, INC. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2013-08-23: Federal exemption Rule 506; Types of securities offered Debt; Convertible Promissory Note; Date of first sale 2013-06-19; Total offering amount $105,500.
  • 2013-06-28: Federal exemption Rule 506; Types of securities offered Debt; Convertible Promissory Note; Date of first sale 2013-06-19; Total offering amount $63,000.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2013-08-23
D/A
Rule 506Debt; Convertible Promissory Note2013-06-19$105,500$105,500$01
2013-06-28Rule 506Debt; Convertible Promissory Note2013-06-19$63,000$63,000$01